Third Nerve Palsy: Rare Adverse Event following Covid-19 Vaccination
Drugs Controller General of India (DCGI) in April 2022 approved the emergency use authorisation of Corbevax and Covaxin COVID 19 vaccines in children. Corbevax is a protein subunit COVID 19 vaccine developed by Texas Children's Hospital. Third nerve palsy is rarely reported following protein s...
Saved in:
Main Authors: | Indira Balasaheb Deshmukh (Author), Shreyas Ramchandra Burute (Author), Shraddha Milind Pore (Author), Atmik Singh (Author) |
---|---|
Format: | Book |
Published: |
Research Center for Rational Use of Drugs (RCRUD),
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adverse drug events monitoring of live attenuated pandemic influenza vaccine
by: Pramod B Akat, et al.
Published: (2011) -
Partial third nerve palsy after Measles Mumps Rubella vaccination
by: Manzotti Francesca, et al.
Published: (2010) -
A rare adverse event following laser hair reduction
by: Corey Stone, MD, et al.
Published: (2024) -
Oculomotor Nerve Palsy due to an Odontogenic Abscess Originating from the Mandibular Third Molar
by: Hee-Keun Park, et al.
Published: (2012) -
Nontraumatic oculomotor nerve palsy following endoscopic sinus surgery
by: Wasan F. Almarzouq, et al.
Published: (2024)